Roohani, S., Krcek, R., Mowery, Y. M., Avery, L., Ballman, K. V., Hong, A. M., … Kirsch, D. G. (2026). Refining Patient Selection for Pembrolizumab in Localized Soft Tissue Sarcoma of the Extremity: A Sarculator-Based Reanalysis of the Randomized SU2C-SARC032 Trial. In ONCOLOGY RESEARCH AND TREATMENT (Vol. 49, pp. 34–35).

Roohani, Siyer, Reinhardt Krcek, Yvonne M. Mowery, Lisa Avery, Karla V. Ballman, Angela M. Hong, Scott M. Schuetze, et al. “Refining Patient Selection for Pembrolizumab in Localized Soft Tissue Sarcoma of the Extremity: A Sarculator-Based Reanalysis of the Randomized SU2C-SARC032 Trial.” In ONCOLOGY RESEARCH AND TREATMENT, 49:34–35, 2026.

Roohani S, Krcek R, Mowery YM, Avery L, Ballman KV, Hong AM, et al. Refining Patient Selection for Pembrolizumab in Localized Soft Tissue Sarcoma of the Extremity: A Sarculator-Based Reanalysis of the Randomized SU2C-SARC032 Trial. In: ONCOLOGY RESEARCH AND TREATMENT. 2026. p. 34–5.

Roohani, Siyer, et al. “Refining Patient Selection for Pembrolizumab in Localized Soft Tissue Sarcoma of the Extremity: A Sarculator-Based Reanalysis of the Randomized SU2C-SARC032 Trial.” ONCOLOGY RESEARCH AND TREATMENT, vol. 49, 2026, pp. 34–35.

Roohani S, Krcek R, Mowery YM, Avery L, Ballman KV, Hong AM, Schuetze SM, Wagner AJ, Monga V, Heise RS, Moding EJ, Weinhold KJ, van de Rijn M, Brigman BE, Riedel RF, Gronchi A, Kirsch DG. Refining Patient Selection for Pembrolizumab in Localized Soft Tissue Sarcoma of the Extremity: A Sarculator-Based Reanalysis of the Randomized SU2C-SARC032 Trial. ONCOLOGY RESEARCH AND TREATMENT. 2026. p. 34–35.